Related Articles
ARID1A gene mutation in ovarian and endometrial cancers (Review)
Candidate synthetic lethality partners to PARP inhibitors in the treatment of ovarian clear cell cancer (Review)
Aberrant chromatin remodeling in gynecological cancer (Review)
Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review)
Modulation of estrogenic action in clear cell carcinoma of the ovary (Review)